Skip to main content

Merck

Merck & Co Inc, known as MSD outside the United States and Canada, is an American multinational biopharmaceutical corporation operating across human health and animal health sectors. The company researches, manufactures, and markets oncology immunotherapies, vaccines, cardiovascular drugs, and animal health products, led by its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. Main revenue drivers derive from global commercial sales of Keytruda oncology treatments, Gardasil vaccines, diabetes treatments, and livestock/pet pharmaceuticals. Merck & Co serves oncologists, hospital networks, government health agencies, prescription pharmacies, and veterinarians globally. The enterprise holds a world-dominant market position in immuno-oncology, cancer therapeutics, and preventive human vaccines. Headquartered in Rahway, New Jersey, Merck & Co Inc is listed on the New York Stock Exchange.

64 of the funds FundTelligence covers report a position in Merck.

Legal name
Merck & Co
Sector
Health Care
Country
United States
Funds holding it
64
Exposure themes
Multiple, Treatment, Women's Health

Funds holding Merck

Showing the 8 largest of 64 funds holding it.

Loading...